Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.50 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.46 |
| ▸ | CASP2 | P42575 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | F13A1 | P00488 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 2/20 | 0.44 |
| ▸ | CA6 | P23280 | 2/20 | 0.44 |
| ▸ | CA5A | P35218 | 2/20 | 0.44 |
| ▸ | THPO | P40225 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Norspermidine SCHEMBL28830161 | 0.96 | ACE2 (0.50) | ACE2CXCR4CASP2CA12F13A1 | |
| SCHEMBL8306593 | 0.94 | ACE2 (0.57) | ACE2CXCR4CA12CA2ALOX15 | |
| SCHEMBL5498811 | 0.92 | ACE2 (0.61) | ACE2CXCR4CASP2CA12F13A1 | |
| SCHEMBL15065607 | 0.90 | CXCR4 (0.54) | ACE2CXCR4ALOX15HSD17B10MEN1 | |
| SCHEMBL26398569 | 0.86 | ACE2 (0.67) | ACE2CASP2CA12F13A1CA2 | |
| SCHEMBL26522670 | 0.85 | ACE2 (0.67) | ACE2CXCR4CA12CA2ALOX15 | |
| SCHEMBL11580070 | 0.84 | ACE2 (0.59) | ACE2CXCR4CA12CA2ALOX15 | |
| SCHEMBL302850 | 0.84 | ACE2 (0.72) | ACE2CXCR4CA12CA2ALOX15 | |
| SCHEMBL15065509 | 0.84 | CXCR4 (0.55) | ACE2CXCR4ALOX15HSD17B10TSHR | |
| SCHEMBL6961878 | 0.83 | CXCR4 (0.56) | ACE2CXCR4ALOX15HSD17B10SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130123108-A1 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | BASF SE (DE) | 2013-05-16 | — | — | US | disclosed |
| US-20110105333-A1 | Seed Treatment Compositions and Methods | BASF SE (DE) | 2011-05-05 | — | — | US | disclosed |
| US-4839175-A | USING CHOLESTEROL DERIVATIVES; FOR OPTHALMIC DRUG DELIVERY | LIPOSOME TECHNOLOGY, INC. (US) | 1989-06-13 | — | — | US | disclosed |
| EP-0316345-A1 | LIPOSOMES WITH ENHANCED RETENTION ON MUCOSAL TISSUE | LIPOSOME TECHNOLOGY, INC. (US) | 1989-05-24 | — | — | EP | disclosed |
| EP-0316345-A4 | LIPOSOMES WITH ENHANCED RETENTION ON MUCOSAL TISSUE. | LIPOSOME TECHNOLOGY INC (US) | 1989-05-16 | — | — | EP | disclosed |
| US-4804539-A | Ophthalmic liposomes | LIPOSOME TECHNOLOGY, INC. (US) | 1989-02-14 | — | — | US | disclosed |
| WO-1988000824-A1 | LIPOSOMES WITH ENHANCED RETENTION ON MUCOSAL TISSUE | LIPOSOME TECHNOLOGY, INC. (US) | 1988-02-11 | — | — | WO | disclosed |
| US-4297516-A | PROSTAGLANDINS | AMERICAN CYANAMID COMPANY (US) | 1981-10-27 | — | — | US | disclosed |
| US-RE30451-E | ANTITUMOR AGENTS | Zaidan Jojin Biseibutsu Kagaku Kenkyu Kai (JP) | 1980-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105333-A1 | Seed Treatment Compositions and Methods | PTK2, BROX, FYN | ACE2 3031/4885CXCR4 4556/4885CASP2 4179/4885 |
| US-20130123108-A1 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | NOS1, NOS3, NPSR1 | ACE2 3472/4885CXCR4 2288/4885CASP2 3441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.